Professor of Medicine
American University of Beirut
Ghada El-Hajj Fuleihan, MD, MPH, FRCP is Professor of Medicine, Physician-Scientist, at the American University of Beirut (AUB), Beirut, Lebanon. She is founding Director of the Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, and of the Scholars in HeAlth Research Program at AUB. Dr El-Hajj Fuleihan obtained her MD degree from the American University of Beirut, completed residency and fellowship training at the New England Deaconess and Brigham and Women’s Hospital, Harvard Medical School, Boston. She holds a master degree in Public Health from the Harvard School of Public Health, Clinical Effectiveness concentration.
She is the PI/PD on multiple investigator initiated grants, including the NIH D43 grant, awarded a 5-year competitive renewal (2020-2025). Her laboratory focuses on generating evidence on the pathophysiology, prevention, and treatment of hypovitaminosis D, osteoporosis, and other metabolic bone disorders. She leads a team that conducts clinical trials, systematic reviews, and meta-analyses, and translates findings into prevention and treatment strategies. She closely collaborates with the Ministry of Health officials and international experts to generate evidence-based national and international clinical care pathways. She has published on her topics of interest in over 205 publications, mostly peer reviewed original investigations, chapters, invited reviews, and penned invited several Editorials, Scientific Position Statements, and commentaries in the New Engl J of Med, JCEM, and Nature Reviews Endocrinology. https://www.aub.edu.lb/fm/CaMOP/Pages/Publications.aspx. Her H-index is 57 and her citation score as per scopus metrics is 10,863 excluding self-citations.
Dr El-Hajj Fuleihan is a member of the Alpha Omega Alpha Medical Honor Society. She is the recipient of the John Bilezikian Leadership Award of the International Society of Clinical Densitometry in 2014, the Endocrine Society International Excellence in Endocrinology award in 2016, and the Harvard T.H.Chan School of Public Health Merit award in 2017.
Tuesday, March 28, 2023
8:00 AM – 5:00 PM
Disclosure(s): ABIOGEN: Other (Terminated, September 4, 2022)